unknown
Stage
3
Investors
About
InSilicoTrials provides an end-to-end in silico simulation platform that integrates mechanistic models, AI, digital twins, and synthetic data to optimize drug development and clinical trial design, reducing time, cost, and reliance on animal testing.
Explore InSilicoTrials's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.